TD Cowen lowered the firm’s price target on Qiagen (QGEN) to $48 from $50 and keeps a Hold rating on the shares. The firm updated its model as its Q3 report reflected solid trends while the Q4 and 2026 outlook were drags.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on QGEN:
- Qiagen’s Hold Rating: Solid Q3 Performance Overshadowed by Uncertainties and Mixed Growth Outlook
- Qiagen’s Hold Rating: Navigating Market Crosswinds and Valuation Concerns
- Qiagen price target lowered to $46 from $49 at Baird
- QIAGEN Announces Q3 Results, Parse Acquisition, and Share Repurchase
- Qiagen Reports Strong Asset Growth in Q3 2025